Q5007 – Hospice care provided in long term care facility
HCPCS Level II code · Q codes: Temporary Codes
HCPCS codeQ5007
- Long description
- Hospice care provided in long term care facility
- Short description
- Hospice in ltch
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
DSpecial coverage instructions apply- BETOS category
Y2Other - Non-Medicare fee schedule- Added
- January 1, 2007
- Last change
- January 1, 2007 – No change
Frequently asked questions
What is HCPCS code Q5007?
Q5007 is a HCPCS Level II code for hospice care provided in long term care facility.
Does Medicare cover Q5007?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby Q codes
- Q4439 – Instagraft, per square centimeter (add-on, list separately in addition to primary procedure)
- Q4440 – Curamatrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Q5001 – Hospice or home health care provided in patient's home/residence
- Q5002 – Hospice or home health care provided in assisted living facility
- Q5003 – Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)
- Q5004 – Hospice care provided in skilled nursing facility (snf)
- Q5005 – Hospice care provided in inpatient hospital
- Q5006 – Hospice care provided in inpatient hospice facility
- Q5008 – Hospice care provided in inpatient psychiatric facility
- Q5009 – Hospice or home health care provided in place not otherwise specified (nos)
- Q5010 – Hospice home care provided in a hospice facility
- Q5098 – Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg
- Q5099 – Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg
- Q5100 – Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg
- Q5101 – Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
- Q5102 – Injection, infliximab, biosimilar, 10 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.